Free tool
Oncology stocks
We cover 162 companies grouped under the Oncology theme. The median market value in the group is $26.85M. Across the group, the median move over the past trading day is +0.71%. 34% of the 158 with a 200-day average trade above it. Price change over the past year runs from −87.8% to +52.7% across the middle 80 percent of the group, with a median of −29.1%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
162 of 319 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| 6MK.DE | Merck & Co., Inc. | 129.28 EUR | +11.62% | +44.70% | +83.96% |
| MRK | Merck & Co., Inc. | $156.45 | +19.65% | +48.06% | +88.17% |
| AZN.L | AstraZeneca PLC | 12,110.00 GBP | −6.41% | −10.89% | +1.98% |
| AZN | AstraZeneca PLC | $169.66 | +0.01% | −6.39% | +7.60% |
| A1ZN34.SA | AstraZeneca PLC | 144.34 BRL | +0.85% | −12.75% | +1.51% |
| BMY | Bristol-Myers Squibb Company | $67.92 | +8.57% | +28.36% | +49.31% |
| 4519.T | Chugai Pharmaceutical Co., Ltd. | 7,050.00 JPY | +0.73% | −17.21% | +12.47% |
| RVMD | Revolution Medicines, Inc. | $211.38 | +12.39% | +167.50% | +492.60% |
| ONC | BeOne Medicines AG | $376.37 | +15.49% | +21.01% | +21.95% |
| 4568.T | Daiichi Sankyo Company, Limited | 2,923.00 JPY | +1.16% | −16.08% | −15.95% |
| BNTX | BioNTech SE | $114.05 | +25.21% | +17.95% | +8.55% |
| INCY | Incyte Corporation | $129.72 | +9.13% | +27.90% | +53.04% |
| GMAB | Genmab A/S | $34.36 | +19.31% | +7.98% | +41.34% |
| GE9.DE | GENMAB AS N | 283.30 EUR | +10.97% | +5.71% | −14.41% |
| 0J9P.L | Incyte Corporation | $130.13 | +1.97% | +30.41% | +53.55% |
| IPN.PA | Ipsen S.A. | 162.60 EUR | +1.37% | +40.05% | +39.21% |
| EXEL | Exelixis, Inc. | $56.72 | +1.63% | +30.15% | +49.66% |
| 0IJO.L | Exelixis, Inc. | $56.16 | +3.33% | +30.00% | +44.33% |
| 0M2N.L | Orion Oyj | 80.50 EUR | +12.46% | +29.29% | +19.68% |
| SMMT | Summit Therapeutics Inc. | $13.36 | +1.95% | −23.74% | −49.14% |
| JATT | JATT II Acquisition Corp. | $12.46 | +11.80% | +18.62% | +18.62% |
| 4575.T | CanBas Co., Ltd. | 821.00 JPY | +12.47% | +0.24% | −40.51% |
| ACRV | Acrivon Therapeutics, Inc. | $2.18 | +39.74% | −11.38% | +63.91% |
| 4579.T | RaQualia Pharma Inc. | 571.00 JPY | +26.05% | −41.26% | +4.58% |
| OSE.PA | OSE Immunotherapeutics SA | 3.19 EUR | +0.69% | −39.85% | −47.82% |
| MAIA | MAIA Biotechnology, Inc. | $1.41 | +10.16% | −11.88% | −10.76% |
| CTOR | Citius Oncology, Inc. | $0.81 | +45.70% | −24.99% | −57.14% |
| 0QW5.L | Heidelberg Pharma AG | 2.46 EUR | +3.36% | −2.38% | −45.58% |
| VRCA | Verrica Pharmaceuticals Inc. | $4.94 | −7.66% | −40.48% | −17.53% |
| 0J4V.L | Heron Therapeutics, Inc. | $0.32 | +1.38% | −74.92% | −76.73% |
| POLB.L | Poolbeg Pharma PLC | 8.50 GBP | +38.21% | +117.95% | +161.54% |
| 4888.T | Stella Pharma Corporation | 364.00 JPY | +17.42% | +71.70% | −9.23% |
| CRDF | Cardiff Oncology, Inc. | $1.02 | +21.43% | −61.65% | −53.85% |
| 0QXX.L | Molecular Partners AG | 3.51 CHF | +2.33% | +3.54% | +22.73% |
| ELTX | Elicio Therapeutics, Inc. | $3.01 | +0.33% | −62.61% | −72.71% |
| APLM | Apollomics, Inc. | $26.50 | +47.22% | +37.31% | +318.64% |
| OSTX | OS Therapies Incorporated | $1.65 | +7.84% | +23.13% | −24.66% |
| PLRX | Pliant Therapeutics, Inc. | $1.14 | +5.56% | −8.80% | −23.49% |
| SAR.L | Sareum Holdings plc | 29.00 GBP | +31.82% | +70.59% | +38.10% |
| XBIT | XBiotech Inc. | $2.30 | +1.77% | −3.36% | −28.13% |
| PMVP | PMV Pharmaceuticals, Inc. | $1.31 | +10.59% | +6.10% | −8.10% |
| BOLD | Boundless Bio, Inc. | $2.94 | +18.55% | +140.98% | +160.18% |
| MAAT.PA | MaaT Pharma SA | 3.05 EUR | +8.75% | −45.43% | −39.58% |
| RNXT | RenovoRx, Inc. | $1.42 | +47.15% | +70.06% | +58.13% |
| HRTX | Heron Therapeutics, Inc. | $0.32 | −29.76% | −74.36% | −76.59% |
| XLO | Xilio Therapeutics, Inc. | $9.08 | −0.11% | −3.49% | −7.35% |
| IMM.AX | Immutep Limited | 0.05 AUD | +14.89% | −87.44% | −77.96% |
| ATX.AX | Amplia Therapeutics Limited | 0.15 AUD | +13.08% | −13.53% | −13.53% |
| IMMP | Immutep Limited | $0.38 | +0.50% | −87.05% | −77.54% |
| 4572.T | Carna Biosciences, Inc. | 416.00 JPY | +40.54% | +3.48% | +83.26% |
| 0OCQ.L | Transgene SA | 0.81 EUR | −0.25% | −16.36% | −18.38% |
| COIL.L | Coiled Therapeutics plc | 9.50 GBP | −5.00% | −20.83% | −26.92% |
| 4564.T | OncoTherapy Science, Inc. | 21.00 JPY | +5.00% | 0.00% | −25.00% |
| 0RAD.L | OSE Immunotherapeutics SA | 3.16 EUR | −2.11% | −40.40% | −48.92% |
| TIL | Instil Bio, Inc. | $7.81 | +9.23% | −30.70% | −69.62% |
| 4597.T | Solasia Pharma K.K. | 29.00 JPY | 0.00% | +3.57% | −23.68% |
| PTX.AX | Prescient Therapeutics Limited | 0.07 AUD | −15.00% | −18.07% | +58.14% |
| CANTA.ST | Cantargia AB (publ) | 1.90 SEK | +1.71% | −53.86% | −28.93% |
| IBO | Impact BioMedical Inc. | $0.46 | +6.53% | −11.33% | −20.79% |
| BKHA | Black Hawk Acquisition Corporation | $11.89 | −1.74% | +5.69% | +8.09% |
| SVE.WA | Synthaverse S.A. | 3.04 PLN | +10.55% | −20.73% | −37.70% |
| 4594.T | BrightPath Biotherapeutics Co., Ltd. | 53.00 JPY | +12.77% | +8.16% | −33.75% |
| HOWL | Werewolf Therapeutics, Inc. | $0.89 | +96.47% | +37.98% | −35.04% |
| 4583.T | Chiome Bioscience Inc. | 85.00 JPY | +25.00% | −20.56% | −36.57% |
| KPTI | Karyopharm Therapeutics Inc. Common Stock | $1.92 | −72.92% | −73.30% | −69.57% |
| MOC.WA | Molecure S.A. | 6.14 PLN | +2.33% | −6.40% | −21.18% |
| CNTX | Context Therapeutics Inc. | $0.44 | −30.00% | −71.91% | −50.13% |
| 206A.T | PRISM BioLab Co.,LTD | 171.00 JPY | +16.33% | +6.21% | −6.56% |
| SNT.AX | Syntara Limited | 0.03 AUD | +18.18% | −23.53% | −1.89% |
| 190A.T | CHORDIA THERAPEUTICS INC | 75.00 JPY | 0.00% | −33.04% | −58.56% |
| ATNM | Actinium Pharmaceuticals, Inc. | $1.08 | +26.46% | −21.17% | −39.66% |
| BCTX | BriaCell Therapeutics Corp. | $3.77 | +6.20% | −47.42% | −49.67% |
| KYNB | Kyntra Bio, Inc. | $8.10 | +14.89% | −11.57% | −23.80% |
| BCT.TO | BriaCell Therapeutics Corp. | 5.14 CAD | +1.98% | −47.66% | −50.62% |
| 4582.T | SymBio Pharmaceuticals Limited | 63.00 JPY | −7.35% | −30.00% | −58.28% |
| BYSI | BeyondSpring Inc. | $0.72 | −38.44% | −55.27% | −60.43% |
| MDNA.TO | Medicenna Therapeutics Corp. | 0.47 CAD | +36.23% | −53.00% | −58.77% |
| EVAX | Evaxion A/S | $3.35 | +15.92% | −28.87% | +4.49% |
| LTRN | Lantern Pharma Inc. | $2.18 | −21.86% | −29.90% | −52.30% |
| NNG.WA | NanoGroup S.A. | 2.47 PLN | +2.28% | −7.84% | −14.09% |
| NXTC | NextCure, Inc. | $5.91 | +15.43% | −55.50% | +13.33% |
| PSTV | Plus Therapeutics Inc | $3.84 | +2.90% | −72.59% | −68.67% |
| ATOS | Atossa Therapeutics, Inc. | $2.68 | +13.56% | −71.64% | −76.49% |
| CVM | CEL-SCI Corporation | $1.48 | +25.42% | −71.26% | −85.98% |
| IMU.AX | Imugene Limited | 0.07 AUD | −16.28% | −81.54% | −73.33% |
| MRKR | Marker Therapeutics, Inc. | $1.52 | +24.59% | −1.30% | +20.63% |
| CLRB | Cellectar Biosciences, Inc. | $2.54 | +4.96% | −26.80% | −45.96% |
| BFRI | Biofrontera Inc. | $1.51 | +43.81% | +108.28% | +63.77% |
| CCM | Concord Medical Services Holdings Limited | $4.95 | +9.76% | +15.93% | −10.65% |
| ABVC | ABVC BioPharma, Inc. | $0.80 | −21.58% | −63.47% | −72.70% |
| ALLR | Allarity Therapeutics, Inc. | $1.33 | +8.13% | +16.67% | +41.34% |
| NOX.AX | Noxopharm Limited | 0.09 AUD | −8.00% | −2.13% | −20.00% |
| DEX.ST | DexTech Medical AB | 10.40 SEK | −0.95% | +12.43% | +20.93% |
| RADX | Radiopharm Theranostics Limited | $2.48 | −32.24% | −51.94% | −55.71% |
| TPST | Tempest Therapeutics, Inc. | $1.11 | +18.72% | −62.37% | −89.50% |
| B8FK.DE | Biofrontera AG | 2.52 EUR | −1.95% | −1.18% | −4.55% |
| ABERA.ST | Abera Bioscience AB | 8.14 SEK | −7.29% | +13.06% | −0.12% |
| 4882.T | Perseus Proteomics Inc. | 149.00 JPY | +2.76% | −34.65% | −56.43% |
| RAD.AX | Radiopharm Theranostics Limited | 0.01 AUD | −33.33% | −60.00% | −62.96% |
| CTXR | Citius Pharmaceuticals, Inc. | $0.60 | +16.77% | −28.81% | −52.09% |
| MDCX | Medicus Pharma Ltd. | $0.26 | −17.92% | −83.69% | −87.97% |
| INTS | Intensity Therapeutics, Inc. | $4.90 | +7.11% | −51.89% | −37.24% |
| LSTA | Lisata Therapeutics, Inc. | $1.74 | +20.83% | −11.22% | −31.23% |
| ACTI.ST | Active Biotech AB (publ) | 5.55 SEK | +7.77% | +20.65% | −60.62% |
| AKTX | Akari Therapeutics, Plc | $7.87 | −6.97% | −32.16% | −77.77% |
| ALTME.PA | TME Pharma N.V. | 0.16 EUR | +147.62% | +126.09% | +48.57% |
| PHIO | Phio Pharmaceuticals Corp. | $1.17 | +11.43% | +7.34% | −41.21% |
| GTBP | GT Biopharma, Inc. | $0.30 | −10.27% | −63.32% | −72.50% |
| BLRX | BioLineRx Ltd. | $2.85 | +1.06% | +1.79% | −25.97% |
| CRTX.L | CRISM Therapeutics Corporation | 11.50 GBP | +21.05% | +15.00% | +9.52% |
| PDSB | PDS Biotechnology Corporation | $0.22 | −68.04% | −73.41% | −82.96% |
| MBRX | Moleculin Biotech, Inc. | $0.61 | −72.10% | −83.12% | −95.75% |
| TOVX | Theriva Biologics, Inc. | $0.24 | +11.95% | −9.58% | −45.33% |
| APRE | Aprea Therapeutics, Inc. | $0.95 | +51.98% | +11.36% | −40.63% |
| 0NWK.L | Valerio Therapeutics Société anonyme | 0.82 EUR | +3.03% | +393.94% | +1214.52% |
| LNAI | Lunai Bioworks Inc. | $2.20 | −1.35% | −71.71% | −87.99% |
| PUR.WA | MultiQure S.A. | 3.14 PLN | +45.81% | −23.35% | −53.66% |
| 4598.T | Delta-Fly Pharma, Inc. | 104.00 JPY | +5.05% | −80.92% | −81.94% |
| XBIO | Xenetic Biosciences, Inc. | $3.82 | +52.80% | +77.67% | +33.57% |
| IMNN | Imunon, Inc. | $1.66 | +8.50% | −57.97% | −73.86% |
| CNSP | CNS Pharmaceuticals, Inc. | $5.80 | +14.40% | +9.43% | −11.31% |
| AIM | AIM ImmunoTech Inc. | $0.25 | +1.60% | −77.99% | −89.97% |
| PAB.AX | Patrys Limited | 0.03 AUD | −22.50% | +14.81% | −11.43% |
| CURX | Curanex Pharmaceuticals Inc | $4.75 | +2495.63% | +1190.76% | +18.16% |
| BOLT | Bolt Biotherapeutics, Inc. | $3.85 | −3.12% | −33.51% | −29.28% |
| CANF | Can-Fite BioPharma Ltd. | $3.32 | +5.40% | −24.55% | −74.46% |
| ALOPM.PA | Oncodesign Precision Medicine Société anonyme | 0.32 EUR | +1.26% | −17.65% | −17.01% |
| CHOSA.ST | CHOSA Oncology AB | 0.73 SEK | −14.59% | −20.22% | −12.00% |
| ITOC | iTonic Holdings Ltd. | $0.27 | +9.68% | −37.07% | −51.75% |
| LIMN | Liminatus Pharma, Inc. | $4.61 | +4375.73% | +619.19% | +35.59% |
| NCNA | NuCana plc | $1.47 | +16.67% | −59.62% | −56.76% |
| PCSA | Processa Pharmaceuticals, Inc. | $2.18 | −15.83% | −25.60% | −60.36% |
| KAPA | Kairos Pharma, Ltd. | $0.25 | −19.94% | −65.95% | −79.82% |
| 0GP7.L | Medivir AB (publ) | 2.08 SEK | +9.14% | +355.54% | +3.85% |
| NFX.L | Nuformix plc | 0.17 GBP | +3.13% | −44.07% | +106.25% |
| PER.AX | PERCHERON FPO [PER] | 0.01 AUD | +25.00% | −47.37% | −54.55% |
| BCAB | BioAtla, Inc. | $3.26 | −4.12% | −87.79% | −81.69% |
| HCWB | HCW Biologics Inc. | $2.60 | −1.89% | +132.14% | −53.15% |
| APVO | Aptevo Therapeutics Inc. | $2.46 | −41.57% | −73.80% | −92.81% |
| APS.TO | Aptose Biosciences Inc | 2.40 CAD | 0.00% | +18.81% | +37.14% |
| OSRH | OSR Health, Inc. | $0.12 | −73.09% | −80.22% | −88.47% |
| CRIS | Curis, Inc. | $1.59 | −66.10% | +62.24% | −3.64% |
| DBP-B.ST | Double Bond Pharmaceutical Int. | 0.15 SEK | +18.62% | +9.33% | +9.33% |
| RDHL | RedHill Biopharma Ltd. | $0.61 | −13.56% | −41.25% | −55.83% |
| CLDI | Calidi Biotherapeutics, Inc. | $1.31 | −25.57% | +11.02% | −16.03% |
| GOVX | GeoVax Labs, Inc. | $0.64 | −15.54% | −87.60% | −96.61% |
| ARTL | Artelo Biosciences, Inc. | $0.72 | −28.99% | −81.18% | −97.47% |
| IVX.AX | Invion Limited | 0.04 AUD | −15.22% | −58.06% | −70.00% |
| VAL.L | ValiRx plc | 0.16 GBP | −3.13% | −57.53% | −73.04% |
| NXTS | Nexentis Technologies Inc. | $1.85 | +10.78% | −83.38% | −96.64% |
| PPBT | Purple Biotech Ltd | $1.65 | +14.58% | −75.00% | −92.53% |
| RNAZ | TransCode Therapeutics, Inc. | $2.53 | −53.58% | −65.81% | −74.16% |
| PPCB | Propanc Biopharma, Inc. | $1.13 | −14.39% | −92.09% | −98.66% |
| 0RK9.L | Alligator Bioscience AB (publ) | 0.03 SEK | −1.31% | −91.40% | −99.22% |
| SLXN | Silexion Therapeutics Corp | $0.37 | −85.57% | −80.59% | −94.88% |
| NX1.AX | Nexalis Therapeutics Limited | 0.01 AUD | 0.00% | −50.00% | −50.00% |
| DCOY | Decoy Therapeutics Inc. | $2.98 | −20.32% | −61.91% | −95.58% |
| ATORX.ST | Alligator Bioscience AB (publ) | 0.03 SEK | −28.13% | −91.12% | −99.30% |
| PTP.DE | Pentixapharm Holding AG N | 1.88 EUR | −4.57% | +22.08% | +8.55% |
| BDRX | Biodexa Pharmaceuticals Plc | $1.18 | −24.84% | −90.41% | −96.20% |
| 0GQU.L | Active Biotech AB (publ) | 5.46 SEK | +5.61% | +7801.59% | +7801.59% |
| APM | Aptorum Group Ltd | $8.41 | −6.45% | +685.98% | +260.94% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.